SCHOTT Continues to Expand U.S. Presence

SourceContract Pharma
Date Published12/02/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Schott Pharmaceuticals Systems
Parent companySchott
Reshoring category:Foreign Direct Investment
Year reshoring announced:2021
Capital investment ($):60
Country(ies) from which reshored:Germany
City reshored to:Lebanon
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Nonmetallic Mineral Products
Product(s) reshoredspecialty glass
What domestic positive factors made reshoring more attractive?Lead time/Time to market, Proximity to customers/market
Find Reshoring Articles